Marker Therapeutics Company Insiders

Marker Therapeutics Management Team Effectiveness

The company has return on total asset (ROA) of (0.4087) % which means that it has lost $0.4087 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7174) %, meaning that it created substantial loss on money invested by shareholders. Marker Therapeutics' management efficiency ratios could be used to measure how well Marker Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/27/2024, Return On Tangible Assets is likely to drop to -0.86. In addition to that, Return On Capital Employed is likely to grow to -0.99. At this time, Marker Therapeutics' Other Current Assets are relatively stable compared to the past year. As of 11/27/2024, Net Tangible Assets is likely to grow to about 53.1 M, while Non Current Assets Total are likely to drop 0.00. As of 11/27/2024, Common Stock Shares Outstanding is likely to grow to about 9.2 M, while Net Loss is likely to drop (39.6 M).

Marker Therapeutics Workforce Comparison

The company has Profit Margin (PM) of (2.78) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.97) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.97.

Marker Therapeutics Insider Trading History

Marker Therapeutics Notable Stakeholders

The success or failure of an entity such as Marker Therapeutics often depends on how effective the management is. Marker Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Marker management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Marker management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Marker Therapeutics' price analysis, check to measure Marker Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marker Therapeutics is operating at the current time. Most of Marker Therapeutics' value examination focuses on studying past and present price action to predict the probability of Marker Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marker Therapeutics' price. Additionally, you may evaluate how the addition of Marker Therapeutics to your portfolios can decrease your overall portfolio volatility.